• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.27% Nasdaq Up 2.45%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    6.98 Up 0.29(4.33%) 4:00PM EDT
    |After Hours : 6.98 0.00 (0.00%) 4:43PM EDT
    Add to Portfolio
    Prev Close:6.69
    Open:6.77
    Bid:6.76 x 7200
    Ask:7.99 x 1000
    1y Target Est:8.81
    Beta:1.57728
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:6.67 - 6.99
    52wk Range:4.90 - 9.89
    Volume:3,716,317
    Avg Vol (3m):3,075,720
    Market Cap:1.32B
    P/E (ttm):N/A
    EPS (ttm):-0.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 4.33%1.32B
    PFEUp 2.56%205.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.10
    Quarterly EPS Est (Sep-15) :-0.22
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, engages in the discovery, development, and commercialization of medicines for cancer patients. The company offers Iclusig (ponatinib), a tyrosine kinase inhibitor (TKI) for the treatment of adult p... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback